Bank of America
CRVS icon

Bank of America’s Corvus Pharmaceuticals CRVS Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$531K Buy
132,729
+34,180
+35% +$137K ﹤0.01% 4776
2025
Q1
$313K Buy
98,549
+1,568
+2% +$4.99K ﹤0.01% 4983
2024
Q4
$519K Buy
96,981
+96,572
+23,612% +$517K ﹤0.01% 4683
2024
Q3
$2.16K Buy
409
+17
+4% +$90 ﹤0.01% 6187
2024
Q2
$713 Buy
+392
New +$713 ﹤0.01% 6392
2024
Q1
Sell
-22
Closed -$39 6840
2023
Q4
$39 Sell
22
-3,150
-99% -$5.58K ﹤0.01% 6579
2023
Q3
$4.63K Sell
3,172
-1,907
-38% -$2.78K ﹤0.01% 6089
2023
Q2
$11.6K Buy
+5,079
New +$11.6K ﹤0.01% 5942
2023
Q1
Sell
-70
Closed -$60 6995
2022
Q4
$60 Sell
70
-184
-72% -$158 ﹤0.01% 6939
2022
Q3
$0 Sell
254
-209
-45% ﹤0.01% 6964
2022
Q2
$0 Sell
463
-1,067
-70% ﹤0.01% 7178
2022
Q1
$2K Sell
1,530
-798
-34% -$1.04K ﹤0.01% 7208
2021
Q4
$6K Buy
+2,328
New +$6K ﹤0.01% 6910
2021
Q3
Sell
-92
Closed 7193
2021
Q2
$0 Sell
92
-9,844
-99% ﹤0.01% 6938
2021
Q1
$31K Buy
+9,936
New +$31K ﹤0.01% 6076
2020
Q2
Sell
-3,619
Closed -$8K 6218
2020
Q1
$8K Sell
3,619
-19,192
-84% -$42.4K ﹤0.01% 5790
2019
Q4
$124K Sell
22,811
-24,616
-52% -$134K ﹤0.01% 5091
2019
Q3
$143K Sell
47,427
-30,821
-39% -$92.9K ﹤0.01% 5062
2019
Q2
$293K Buy
78,248
+6,665
+9% +$25K ﹤0.01% 4696
2019
Q1
$287K Sell
71,583
-8,698
-11% -$34.9K ﹤0.01% 4629
2018
Q4
$294K Buy
80,281
+19,451
+32% +$71.2K ﹤0.01% 4561
2018
Q3
$522K Buy
60,830
+6,813
+13% +$58.5K ﹤0.01% 4249
2018
Q2
$593K Buy
54,017
+1,358
+3% +$14.9K ﹤0.01% 4142
2018
Q1
$607K Buy
52,659
+44,970
+585% +$518K ﹤0.01% 4055
2017
Q4
$79K Buy
7,689
+7,298
+1,866% +$75K ﹤0.01% 5063
2017
Q3
$6K Buy
391
+390
+39,000% +$5.99K ﹤0.01% 5856
2017
Q2
$0 Sell
1
-2,781
-100% ﹤0.01% 6146
2017
Q1
$58K Sell
2,782
-82
-3% -$1.71K ﹤0.01% 5121
2016
Q4
$41K Buy
2,864
+530
+23% +$7.59K ﹤0.01% 5240
2016
Q3
$39K Buy
2,334
+75
+3% +$1.25K ﹤0.01% 5067
2016
Q2
$32K Buy
+2,259
New +$32K ﹤0.01% 5231